Systemic mast cell disease

disorder

SNOMED 397016004CUI C0221013

Overview

Source: MedlinePlus.gov, National Library of Medicine. Not a substitute for medical advice.

Treatments & Interventions

Imatinib mesylate

substance

Imatinib

substance

Midostaurin

substance

Research Evidence

Peer-reviewed studies linked via MeSH term "Mastocytosis, Systemic" from the MEDLINE/PubMed database.

Sort:

Sugammadex in systemic mastocytosis : Case report and a systematic review of literature.

[object Object], [object Object], [object Object] et al. · Anaesthesiologie · 2022

PMID: 34755218Meta-AnalysisFull text (PMC)

Indirect treatment comparisons of avapritinib versus midostaurin for patients with advanced systemic mastocytosis.

[object Object], [object Object], [object Object] et al. · Future Oncol · 2022

PMID: 35114819Meta-Analysis

Natural history and treatment of cutaneous and systemic mastocytosis.

[object Object], [object Object], [object Object] et al. · Postgrad Med · 2017

PMID: 28770635Meta-Analysis

Are inflammatory cells increased in painful human tendinopathy? A systematic review.

[object Object], [object Object], [object Object] et al. · Br J Sports Med · 2016

PMID: 26246419Meta-Analysis

Systemic mastocytosis--a systematic review.

[object Object], [object Object], [object Object] et al. · Dan Med J · 2012

PMID: 22381091Meta-Analysis

Thyroid autoimmunity and miscarriage: a meta-analysis.

[object Object], [object Object] · Clin Endocrinol (Oxf) · 2011

PMID: 21198746Meta-Analysis

[Systemic mastocytosis: systematic review].

[object Object], [object Object], [object Object] et al. · An Med Interna · 2008

PMID: 18560682Meta-Analysis

Avapritinib versus Placebo in Indolent Systemic Mastocytosis.

[object Object], [object Object], [object Object] et al. · NEJM Evid · 2023

PMID: 38320129RCT

Randomized controlled trial of omalizumab in treatment-resistant systemic and cutaneous mastocytosis (ROAM).

[object Object], [object Object], [object Object] et al. · J Allergy Clin Immunol Pract · 2023

PMID: 37088371RCT

Midostaurin in Advanced Systemic Mastocytosis.

[object Object], [object Object], [object Object] et al. · N Engl J Med · 2016

PMID: 27355555RCT

Search all PubMed articles for Systemic mast cell disease

Research data from MEDLINE/PubMed

Signs & Symptoms

Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.

Cutaneous mastocytosis

HP:0200151

Erythema

HP:0010783

Hives

HP:0001025

Hyperpigmented macules

HP:0001034

Soft tissue swelling

HP:0000969

Telangiectasia macularis eruptiva perstans

HP:0007583

Related Conditions

Indolent systemic mastocytosis(child)

Malignant mastocytosis(child)

Isolated bone marrow mastocytosis(child)

Systemic disease(parent)

Mast cell neoplasm(parent)

Quick Facts

SNOMED CT: 397016004
UMLS CUI: C0221013
Fully Specified Name: Systemic mast cell disease (disorder)
Specialists: 0
Diagnostic Biomarkers: 0
HPO Phenotypes: 6
Known Treatments: 3

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.